The Department of Defense this week announced a notable contract award related to the field of chemical, biological, radiological and nuclear (CBRN) defense or life science research of interest for potential applications in biodefense:
The University of Maryland-Baltimore County (UMBC), Baltimore, Md., is being awarded a $7,899,583 cost-reimbursement contract by the Defense Advanced Research Projects Agency (DARPA) for research and development in support of the Biologically-Derived Medicines on Demand (Bio-MOD) program to provide battlefield medical supply for front line military medics that is responsive to emergency settings and emergent in-theater needs.
The contract includes one, 24-month option which, if exercised, would bring the potential value of this contract to $15,598,291. Work will be performed in Baltimore, Md., and work is expected to be completed April 24, 2015. If options are exercised, work will continue through April 2017.
Fiscal 2013 Research, Development, Test and Evaluation funds will be obligated at the time of award. Contract funds will not expire at the end of the current fiscal year. This contract was competitively procured via broad agency announcement (BAA 12-37), and published on the Federal Business Opportunities website, with twelve offers received. The Space and Naval Warfare Systems Center Pacific, San Diego, Calif., is the contracting activity (N66001-13-C-4023).
Source: DoD Contracts
